Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - liothyronine sodium - tablet - liothyronine sodium 25 µg - thyroid therapy

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharma group ltd - liothyronine sodium - powder for solution for injection - 20 microgram(s) - thyroid hormones; liothyronine sodium

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine 10 [hp_x] in 1 ml - for the temporary relief of symptoms such as backache, constipation, and vomiting.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for the temporary relief of symptoms such as backache, constipation, and vomiting.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. liothyronine sodium tablets are indicated as an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer. liothyronine sodium tablets are indicated as a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy. limitations of use - liothyronine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with liothyronine sodium tablets may induce hyperthyroidism [see warnings and precautions (5.4)]. - liothyronine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. liothyronine sodium tablets are contraindicated in patients with uncorrected ad

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - liothyronine sodium (unii: gca9vv7d2n) (liothyronine - unii:06lu7c9h1v) - liothyronine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. liothyronine sodium tablets are indicated as an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer. liothyronine sodium tablets are indicated as a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy. limitations of use - liothyronine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with liothyronine sodium tablets may induce hyperthyroidism [see warnings and precautions (5.4)]. - liothyronine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. liothyronine sodium tablets are contraindicated in patients with uncorrected ad

Ireland - English - HPRA (Health Products Regulatory Authority)

mercury pharma group limited - liothyronine sodium - tablets - 20 microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

half grain) tablets (imported (united states) - liothyronine sodium; levothyroxine sodium anhydrous - oral tablet - 4.5microgram ; 19microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

2 grains) tablets (imported (united states) - liothyronine sodium; levothyroxine sodium anhydrous - oral tablet - 18microgram ; 76microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

quarter grain) tablets (imported (united states) - liothyronine sodium; levothyroxine sodium anhydrous - oral tablet - 2.25microgram ; 9.5microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

half grain) tablets (imported (united states) - liothyronine sodium; levothyroxine sodium anhydrous - oral tablet - 4.5microgram ; 19microgram